Ideas to Action:

Independent research for global prosperity

Tag: ebola

 

Photo of a hand with a syringe and a vaccine

Global Health Security in the Trump Era: Time to Worry?

Is it time to ring the alarm bell on a declining US commitment to global health security? For most of the past year, I would have said no. But after the last few weeks, I’m starting to think so. And the simultaneous news of a new Ebola outbreak in the Democratic Republic of Congo underscores the stakes at play here.

Research in the Time of Ebola: How We Can Do Better

The 2014-2015 Ebola outbreak in West Africa was a disturbing demonstration of the inadequacy of international institutions to assist the affected peoples or learn how to better treat and prevent their illness. Experts on a CGD panel discussed their experiences working on crisis response during the Ebola outbreak—and how we can do better.

Are We Ready for the Next Pandemic? – CGD Podcast

Consider this statement: Science knows how to deal with a pandemic outbreak, but policy gets in the way. That was how we framed a recent event at CGD with key people who led the US government’s response to the Ebola outbreak in 2014. Drawing from that event, this podcast brings you some ideas of how to improve the global system of response and increase our preparedness for the next inevitable outbreak. Speakers include Jeremy Konyndyk, Amy Pope, David Smith, Rebecca Martin, and Amanda Glassman.

Publications

In this paper, I examine the effects of power sharing on vulnerability to adverse shocks in a multiethnic setting.

GAO Report Misses the Point on USG Ebola Response

Having tried and mostly failed to track what was going on with US Government performance and spending on Ebola, I welcome the GAO’s overview of obligations and disbursements by appropriation account and strategy pillar. Now the scope of this report appears to be narrow, so let’s hope there’s more to come. A performance audit should go beyond the money to look at what actually happened; what organizations, activities and products were funded; what were the results on the outcomes that matter—Ebola transmission, rapid control of Ebola outbreaks; whether second-order economic impacts were mitigated; and how outbreak preparedness has evolved over time.

Publications

On April 7, 2016, CGD’s vice president for programs and director of global health policy Amanda Glassman testified before the Senate Foreign Relations Subcommittee on Africa and Global Health Policy at a hearing examining progress made in addressing the West Africa Ebola epidemic and its secondary effects.

Pages